Literature DB >> 26897514

Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent - A population based study from the DAHANCA group.

Nina Munk Lyhne1, Jørgen Johansen2, Claus A Kristensen3, Elo Andersen4, Hanne Primdahl5, Lisbeth J Andersen6, Charlotte R Bøje7, Anni R Jensen7, Jens Overgaard7.   

Abstract

PURPOSE: To describe the pattern of failure in a national consecutive cohort of patients with glottic squamous cell carcinomas (SCC) treated with primary radiotherapy (RT) with curative intent over a 41-year period.
MATERIALS AND METHODS: All patients undergoing curative treatment for a glottic SCC diagnosed in Denmark between 1971 and 2011 were included and followed from the first contact with the oncology center to death or February 15, 2015.
RESULTS: 5001 patients were identified of whom 98% had primary RT. The median follow-up was 9.1 years/5.7 years (patients alive/patients who died). Ten patients were lost to follow-up. In total 1511 failures were observed; of these 93%, 11% and 5% included T site, N site, and M site, respectively. For patients diagnosed in the 70s and the 00s, respectively, the five-year incidences were: local failure (32% vs 19%), loco-regional failure (34% vs 21%), laryngectomy (26% vs 10%), laryngectomy-free survival (48% vs 62%), disease-free survival (62% vs 68%), and overall survival (62% vs 68%). The five-year incidence of ultimate failure (13-16%) remained statistically unchanged.
CONCLUSION: From the 70s to the 00s a continually improving primary disease-control was observed with a concurrent decrease in the incidence of laryngectomy. The survival rate was significantly higher in the 00s compared to the previous three decades.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Glottic; Laryngeal; Pattern of failure; Radiotherapy; Squamous cell carcinoma; Ultimate control

Mesh:

Year:  2016        PMID: 26897514     DOI: 10.1016/j.radonc.2016.02.006

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  T1-2 glottic cancer treated with radiotherapy and/or surgery.

Authors:  Mohamed Shelan; Lukas Anschuetz; Adrian D Schubert; Beat Bojaxhiu; Alan Dal Pra; Frank Behrensmeier; Daniel M Aebersold; Roland Giger; Olgun Elicin
Journal:  Strahlenther Onkol       Date:  2017-05-04       Impact factor: 3.621

2.  Outcomes of salvage surgery for the oropharynx and larynx: a contemporary experience in a UK Cancer Centre.

Authors:  Ashley Hay; Ricard Simo; Gillian Hall; Selvam Tharavai; Richard Oakley; Alastair Fry; Luke Cascarini; Mary Lei; Teresa Guerro-Urbano; Jean-Pierre Jeannon
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-21       Impact factor: 2.503

3.  Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study.

Authors:  Olgun Elicin; Ekin Ermiş; Christoph Oehler; Daniel M Aebersold; Francesca Caparrotti; Frank Zimmermann; Gabriela Studer; Guido Henke; Lukas Adam; Lukas Anschuetz; Mahmut Ozsahin; Matthias Guckenberger; Mohamed Shelan; Nuri Kaydıhan; Oliver Riesterer; Robin J D Prestwich; Thierry Spielmann; Roland Giger; Mehmet Şen
Journal:  Front Oncol       Date:  2019-09-20       Impact factor: 6.244

Review 4.  Prognostic factors in laryngeal squamous cell carcinoma.

Authors:  Carol R Bradford; Alfio Ferlito; Kenneth O Devaney; Antti A Mäkitie; Alessandra Rinaldo
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-01-27

5.  A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology).

Authors:  Olgun Elicin; Paul Martin Putora; Marco Siano; Martina A Broglie; Christian Simon; Daniel Zwahlen; Gerhard F Huber; Giorgio Ballerini; Lorenza Beffa; Roland Giger; Sacha Rothschild; Sandro V Negri; Pavel Dulguerov; Guido Henke
Journal:  Front Oncol       Date:  2019-10-24       Impact factor: 6.244

6.  Evaluation of Risk Factors for Laryngeal Squamous Cell Carcinoma: A Single-Center Retrospective Study.

Authors:  Qihe Zhang; Huanhuan Wang; Qin Zhao; Yuyu Zhang; Zhuangzhuang Zheng; Shiyu Liu; Zijing Liu; Lingbin Meng; Ying Xin; Xin Jiang
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 7.  Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.

Authors:  Hideya Yamazaki; Gen Suzuki; Satoaki Nakamura; Ken Yoshida; Koji Konishi; Teruki Teshima; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

8.  Randomized controlled single-blinded clinical trial of functional voice outcome after vascular targeting KTP laser microsurgery of early laryngeal cancer.

Authors:  Sebastian Strieth; Benjamin P Ernst; Ina Both; Daniel Hirth; Lara N Pfisterer; Julian Künzel; Katharina Eder
Journal:  Head Neck       Date:  2019-01-31       Impact factor: 3.147

9.  Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients.

Authors:  Gerhard Dyckhoff; Rolf Warta; Christel Herold-Mende; Elisabeth Rudolph; Peter K Plinkert; Heribert Ramroth
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639

10.  Radiotherapy for T3N0 glottic carcinoma without cord fixation: elective nodal irradiation or not?

Authors:  Ryo Toya; Ryuji Murakami; Daizo Murakami; Tetsuo Saito; Tomohiko Matsuyama; Yutaka Toya; Yasuyuki Yamashita; Natsuo Oya
Journal:  Oncotarget       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.